Ironwood Pharmaceuticals Inc
IRWD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001446847
In the last 90 days, Ironwood Pharmaceuticals Inc insiders filed 0 open-market purchases and 1 sale; 212 institutions reported holding it in 13F filings for Q2 2026, worth $675.8M in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding Ironwood Pharmaceuticals Inc changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 199 | 4 | 227 | +32 |
| Shares | 154.6M | 16.0M | 161.5M | +22.8M (+16.5%) |
| Value | $520.2M | $53.9M | $566.8M | +$100.5M (+21.5%) |
4 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (57)
Institutions that held Ironwood Pharmaceuticals Inc at the end of Q1 2026 but not at the end of Q4 2025.
Sold out (25)
Institutions that held Ironwood Pharmaceuticals Inc at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Two Sigma Advisers, LP | 3,140,100 | $10.6M |
| Diadema Partners LP | 683,611 | $2.30M |
| Exome Asset Management LLC | 648,532 | $2.19M |
| Persistent Asset Partners Ltd | 182,046 | $613.5K |
| Prelude Capital Management, LLC | 136,507 | $460.0K |
| Exchange Traded Concepts, LLC | 76,554 | $258.0K |
| Balyasny Asset Management LLC | 65,156 | $219.6K |
| Panagora Asset Management Inc | 54,408 | $183.4K |
| Polymer Capital Management (US) LLC | 48,747 | $164.3K |
| XTX Topco Ltd | 43,904 | $148.0K |
| Jain Global LLC | 30,009 | $101.1K |
| Diversified Trust Co | 12,574 | $42.4K |
| Kaufman Rossin Wealth, LLC | 10,516 | $35.4K |
| Jump Financial, LLC | 10,062 | $33.9K |
| Fisher Asset Management, LLC | 10,000 | $33.7K |
| Harbor Capital Advisors, Inc. | 7,902 | $27.0K |
| GWM Advisors LLC | 5,793 | $19.5K |
| Amalgamated Bank | 5,027 | $17.0K |
| Bessemer Group Inc | 932 | $3.00K |
| Optima Capital LLC | 778 | $2.62K |
| Daiwa Securities Group Inc. | 573 | $2.00K |
| Flagship Harbor Advisors, LLC | 300 | $1.01K |
| Torren Management, LLC | 72 | $243 |
| Garner Asset Management Corp | 50 | $169 |
| Clearstead Advisors, LLC | 41 | $139 |
Not filed for Q1 2026 yet (4)
Institutions that held Ironwood Pharmaceuticals Inc at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Vanguard Group Inc | 15,958,196 | $53.8M |
| CIBC World Markets Corp | 10,585 | $35.7K |
| EMC Capital Management | 8,386 | $28.0K |
| Global Retirement Partners, LLC | 2,713 | $9.14K |